Skip to main content
OpenTrials

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,811 public trials 85 recruiting studies
Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

NCT02612922

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Influence Study Site Hot Springs, Arkansas, United States
  • Influence Study Site Anaheim, California, United States
  • Influence Study Site Fresno, California, United States
  • Influence Study Site Lomita, California, United States
View all 28 locations
View Trial Details
Completed

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

NCT02218697

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +10 more
Locations
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site Angers, France
  • GSK Investigational Site Laval, France
  • GSK Investigational Site Nantes, France
View Trial Details
Completed

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

NCT01517191

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Vancouver General Vancouver, British Columbia, Canada
  • The Moncton Hospital Moncton, New Brunswick, Canada
  • Saint John Regional Hospital Saint John, New Brunswick, Canada
  • QEII Health Science Centre Halifax, Nova Scotia, Canada
View all 14 locations
View Trial Details
Completed

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

NCT01610245

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Influence Study Site Birmingham, Alabama, United States
  • Influence Study Site Dothan, Alabama, United States
  • Influence Study Site Hoover, Alabama, United States
  • Influence Study Site Mobile, Alabama, United States
View all 167 locations
View Trial Details
Completed

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

NCT00979602

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 38 locations
View Trial Details

Related conditions